EPC

EPC
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $537.2M ▼ | $179.4M ▼ | $-30.6M ▼ | -5.696% ▼ | $-0.66 ▼ | $-15.2M ▼ |
| Q3-2025 | $627.2M ▲ | $214.8M ▲ | $29.1M ▲ | 4.64% ▼ | $0.61 ▲ | $78.7M ▼ |
| Q2-2025 | $580.7M ▲ | $197.3M ▲ | $29M ▲ | 4.994% ▲ | $0.6 ▲ | $83.3M ▲ |
| Q1-2025 | $478.4M ▼ | $171.3M ▼ | $-2.1M ▼ | -0.439% ▼ | $-0.043 ▲ | $38.8M ▼ |
| Q4-2024 | $517.6M | $192.4M | $8.8M | 1.7% | $-1.81 | $44.3M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $225.7M ▲ | $3.756B ▼ | $2.203B ▼ | $1.553B ▼ |
| Q3-2025 | $199.6M ▲ | $3.793B ▲ | $2.225B ▼ | $1.568B ▲ |
| Q2-2025 | $170.1M ▼ | $3.773B ▲ | $2.259B ▲ | $1.514B ▲ |
| Q1-2025 | $175.5M ▼ | $3.702B ▼ | $2.201B ▲ | $1.501B ▼ |
| Q4-2024 | $209.1M | $3.731B | $2.147B | $1.584B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $29.1M ▲ | $114.8M ▲ | $-12.3M ▲ | $-83.4M ▼ | $29.5M ▲ | $99.3M ▲ |
| Q2-2025 | $29M ▲ | $45.1M ▲ | $-17.3M ▼ | $-37.4M ▼ | $-5.4M ▲ | $28M ▲ |
| Q1-2025 | $-2.1M ▼ | $-115.6M ▼ | $-15.7M ▲ | $109.9M ▲ | $-33.6M ▼ | $-132.4M ▼ |
| Q4-2024 | $8.8M ▼ | $73.7M ▼ | $-25.5M ▼ | $-40.1M ▲ | $13M ▲ | $47.8M ▼ |
| Q3-2024 | $49M | $101.2M | $-17.2M | $-79.9M | $-100K | $88.6M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
Infant Care and Other Products | $50.00M ▲ | $50.00M ▲ | $50.00M ▲ | $50.00M ▲ |
Razors and blades | $290.00M ▲ | $270.00M ▼ | $260.00M ▼ | $290.00M ▲ |
Shaving gels and creams | $30.00M ▲ | $30.00M ▲ | $30.00M ▲ | $30.00M ▲ |
Skin Care Products | $20.00M ▲ | $20.00M ▲ | $20.00M ▲ | $20.00M ▲ |
Sun care products | $70.00M ▲ | $50.00M ▼ | $160.00M ▲ | $180.00M ▲ |
Tampons Pads and Liners | $70.00M ▲ | $60.00M ▼ | $60.00M ▲ | $70.00M ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Taken together, Edgewell looks like a steady, defensive consumer products business that is trying to reinvent parts of its portfolio. Financially, revenue is stable with modest growth, profitability is positive but not especially strong, and cash flow is reliable. The balance sheet is sound, with moderate leverage and less cash than in the past but no obvious signs of strain. Competitively, the company relies on established brands, retailer relationships, and targeted innovation to hold share in crowded categories. The main opportunities lie in sharpening its focus on higher‑growth segments, digital channels, and sustainability, while the main risks are ongoing margin pressure and the challenge of standing out against much larger rivals.
NEWS
November 25, 2025 · 12:21 PM UTC
Edgewell Personal Care to Webcast Fireside Chat at the Morgan Stanley Global Consumer and Retail Conference
Read more
November 13, 2025 · 6:00 AM UTC
Edgewell Personal Care Announces Fourth Quarter and Fiscal 2025 Results; Provides 2026 Outlook
Read more
November 12, 2025 · 4:24 PM UTC
Essity acquires Edgewell's feminine care business in North America including the brands Carefree, Stayfree and Playtex
Read more
November 12, 2025 · 4:12 PM UTC
Edgewell Personal Care Announces Sale of Feminine Care Business to Essity for $340M
Read more
October 30, 2025 · 7:00 AM UTC
Zachry Group Awarded Engineering, Procurement, and Construction (EPC) Contract for NiSource's Combined Cycle Generation Project
Read more
About Edgewell Personal Care Company
https://edgewell.comEdgewell Personal Care Company, together with its subsidiaries, manufactures and markets personal care products worldwide. It operates through three segments: Wet shave, Sun and Skin care, and Feminine care.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $537.2M ▼ | $179.4M ▼ | $-30.6M ▼ | -5.696% ▼ | $-0.66 ▼ | $-15.2M ▼ |
| Q3-2025 | $627.2M ▲ | $214.8M ▲ | $29.1M ▲ | 4.64% ▼ | $0.61 ▲ | $78.7M ▼ |
| Q2-2025 | $580.7M ▲ | $197.3M ▲ | $29M ▲ | 4.994% ▲ | $0.6 ▲ | $83.3M ▲ |
| Q1-2025 | $478.4M ▼ | $171.3M ▼ | $-2.1M ▼ | -0.439% ▼ | $-0.043 ▲ | $38.8M ▼ |
| Q4-2024 | $517.6M | $192.4M | $8.8M | 1.7% | $-1.81 | $44.3M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $225.7M ▲ | $3.756B ▼ | $2.203B ▼ | $1.553B ▼ |
| Q3-2025 | $199.6M ▲ | $3.793B ▲ | $2.225B ▼ | $1.568B ▲ |
| Q2-2025 | $170.1M ▼ | $3.773B ▲ | $2.259B ▲ | $1.514B ▲ |
| Q1-2025 | $175.5M ▼ | $3.702B ▼ | $2.201B ▲ | $1.501B ▼ |
| Q4-2024 | $209.1M | $3.731B | $2.147B | $1.584B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $29.1M ▲ | $114.8M ▲ | $-12.3M ▲ | $-83.4M ▼ | $29.5M ▲ | $99.3M ▲ |
| Q2-2025 | $29M ▲ | $45.1M ▲ | $-17.3M ▼ | $-37.4M ▼ | $-5.4M ▲ | $28M ▲ |
| Q1-2025 | $-2.1M ▼ | $-115.6M ▼ | $-15.7M ▲ | $109.9M ▲ | $-33.6M ▼ | $-132.4M ▼ |
| Q4-2024 | $8.8M ▼ | $73.7M ▼ | $-25.5M ▼ | $-40.1M ▲ | $13M ▲ | $47.8M ▼ |
| Q3-2024 | $49M | $101.2M | $-17.2M | $-79.9M | $-100K | $88.6M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
Infant Care and Other Products | $50.00M ▲ | $50.00M ▲ | $50.00M ▲ | $50.00M ▲ |
Razors and blades | $290.00M ▲ | $270.00M ▼ | $260.00M ▼ | $290.00M ▲ |
Shaving gels and creams | $30.00M ▲ | $30.00M ▲ | $30.00M ▲ | $30.00M ▲ |
Skin Care Products | $20.00M ▲ | $20.00M ▲ | $20.00M ▲ | $20.00M ▲ |
Sun care products | $70.00M ▲ | $50.00M ▼ | $160.00M ▲ | $180.00M ▲ |
Tampons Pads and Liners | $70.00M ▲ | $60.00M ▼ | $60.00M ▲ | $70.00M ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Taken together, Edgewell looks like a steady, defensive consumer products business that is trying to reinvent parts of its portfolio. Financially, revenue is stable with modest growth, profitability is positive but not especially strong, and cash flow is reliable. The balance sheet is sound, with moderate leverage and less cash than in the past but no obvious signs of strain. Competitively, the company relies on established brands, retailer relationships, and targeted innovation to hold share in crowded categories. The main opportunities lie in sharpening its focus on higher‑growth segments, digital channels, and sustainability, while the main risks are ongoing margin pressure and the challenge of standing out against much larger rivals.
NEWS
November 25, 2025 · 12:21 PM UTC
Edgewell Personal Care to Webcast Fireside Chat at the Morgan Stanley Global Consumer and Retail Conference
Read more
November 13, 2025 · 6:00 AM UTC
Edgewell Personal Care Announces Fourth Quarter and Fiscal 2025 Results; Provides 2026 Outlook
Read more
November 12, 2025 · 4:24 PM UTC
Essity acquires Edgewell's feminine care business in North America including the brands Carefree, Stayfree and Playtex
Read more
November 12, 2025 · 4:12 PM UTC
Edgewell Personal Care Announces Sale of Feminine Care Business to Essity for $340M
Read more
October 30, 2025 · 7:00 AM UTC
Zachry Group Awarded Engineering, Procurement, and Construction (EPC) Contract for NiSource's Combined Cycle Generation Project
Read more

CEO
Rod R. Little
Compensation Summary
(Year 2024)

CEO
Rod R. Little
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2015-07-01 | Forward | 1349:1000 |
Ratings Snapshot
Rating : A-
Most Recent Analyst Grades

Canaccord Genuity
Buy

RBC Capital
Outperform

Wells Fargo
Overweight

Barclays
Equal Weight

Morgan Stanley
Equal Weight

UBS
Neutral
Grade Summary
Price Target
Institutional Ownership

BLACKROCK INC.
7.673M Shares
$137.044M

BLACKROCK, INC.
6.946M Shares
$124.064M

VANGUARD GROUP INC
5.744M Shares
$102.593M

BRANDES INVESTMENT PARTNERS, LP
5.258M Shares
$93.9M

AMERICAN CENTURY COMPANIES INC
3.95M Shares
$70.55M

DIMENSIONAL FUND ADVISORS LP
2.921M Shares
$52.168M

BLACKROCK ADVISORS LLC
2.574M Shares
$45.968M

BLACKROCK FUND ADVISORS
2.289M Shares
$40.876M

BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A.
1.969M Shares
$35.165M

STATE STREET CORP
1.729M Shares
$30.876M

LSV ASSET MANAGEMENT
1.338M Shares
$23.896M

BLACKROCK GROUP LTD
1.289M Shares
$23.014M

GEODE CAPITAL MANAGEMENT, LLC
1.095M Shares
$19.554M

INVESTMENT COUNSELORS OF MARYLAND LLC
1.055M Shares
$18.834M

CHARLES SCHWAB INVESTMENT MANAGEMENT INC
917.172K Shares
$16.381M

GAMCO INVESTORS, INC. ET AL
866.107K Shares
$15.469M

WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
733.889K Shares
$13.107M

CITADEL ADVISORS LLC
672.911K Shares
$12.018M

AMERIPRISE FINANCIAL INC
642.043K Shares
$11.467M

JANUS HENDERSON INVESTORS US LLC
618.308K Shares
$11.043M
Summary
Only Showing The Top 20

